3,4-Dichloromethylphenidate

From Self-sufficiency
Revision as of 20:46, 18 August 2010 by Edgar181 (Talk) (Removed Category:Acetates; Adding category Category:Methyl esters (using HotCat))

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
3,4-Dichloromethylphenidate
200px
Systematic (IUPAC) name
methyl (2R)-2-(3,4-dichlorophenyl)-2-[(2R)-piperidin-2-yl]acetate
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Unscheduled
Identifiers
ATC code none
PubChem CID 44296390
Chemical data
Formula C14H17Cl2NO2
Molar mass 302.196 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

threo-3,4-Dichloromethylphenidate (3,4-CTMP) is a stimulant drug related to methylphenidate. It is around 7x more potent than methylphenidate in animal studies, but has weaker reinforcing effects due to its slower onset of action.[1][2][3][4][5]

See also

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />



  1. Deutsch, H.; Shi, Q.; Gruszecka-Kowalik, E.; Schweri, M. (1996). "Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs". Journal of Medicinal Chemistry. 39 (6): 1201–1209. doi:10.1021/jm950697c. PMID 8632426.  edit
  2. Wayment HK, Deutsch H, Schweri MM, Schenk JO. Effects of methylphenidate analogues on phenethylamine substrates for the striatal dopamine transporter: potential as amphetamine antagonists? Journal of Neurochemistry. 1999 Mar;72(3):1266-74. PMID 10037500
  3. Schweri MM, Deutsch HM, Massey AT, Holtzman SG. Biochemical and behavioral characterization of novel methylphenidate analogs. Journal of Pharmacology and Experimental Therapeutics. 2002 May;301(2):527-35. PMID 11961053
  4. Davies HM, Hopper DW, Hansen T, Liu Q, Childers SR. Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites. Bioorganic and Medicinal Chemistry Letters. 2004 Apr 5;14(7):1799-802. PMID 15026075
  5. Kim DI, Deutsch HM, Ye X, Schweri MM. Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate. Journal of Medicinal Chemistry. 2007 May 31;50(11):2718-31. PMID 17489581